微针导入类人胶原蛋白在面部年轻化治疗中的效果

目的 探讨微针导入类人胶原蛋白在面部年轻化治疗中的临床效果。方法 选取2021年10月-2022年9月于我院接受面部年轻化治疗的30例患者为研究对象，所有患者均采取微针导入类人胶原蛋白进行治疗，比较治疗前后皮肤状态问卷调查结果、VISIA及Soft 5.5检测结果、临床疗效、不良反应发生率及满意度。结果 治疗后皮肤敏感、弹性、出油、刺痒、干燥、光泽、色素、发红、松弛以及纹理评分均高于治疗前，差异有统计学意义（P＜0.05）；治疗后VISIA及Soft 5.5对皱纹、弹性、水分、色斑、毛孔、纹理的评分及PH值均高于治疗前，油脂评分低于治疗前，差异有统计学意义（P＜0.05）；治疗总有效率为96.67%；不良反应发生率为10.00%；治疗满意度为93.33%。结论 微针导入类人胶原蛋白应用于面部年轻化治疗中，可以有效改善皮肤状态，且疗效确切，安全性较高，患者满意度较高，值得临床应用。

Effect of Microneedle Introduction of Human-like Collagen in Facial Rejuvenation Treatment

Objective To investigate the clinical effect of microneedle introduction of human-like collagen in facial rejuvenation treatment. Methods Thirty patients who received facial rejuvenation treatment in our hospital from October 2021 to September 2022 were selected as the research objects. All patients were treated with microneedle introduction of human-like collagen. The results of skin state questionnaire, VISIA and Soft 5.5 test results, clinical efficacy, incidence of adverse reactions and satisfaction before and after treatment were compared. Results After treatment, the scores of skin sensitivity, elasticity, oil, itching, dryness, luster, pigment, redness, relaxation and texture were higher than those before treatment, and the differences were statistically significant (P<0.05). After treatment, the scores of wrinkles, elasticity, moisture, color spots, pores, texture and PH value of VISIA and Soft 5.5 were higher than those before treatment, and the oil score was lower than that before treatment, the differences were statistically significant (P<0.05). The total effective rate was 96.67%. The incidence of adverse reactions was 10.00%. The treatment satisfaction was 93.33%. Conclusion The application of microneedle-induced human-like collagen in facial rejuvenation treatment can effectively improve the skin state, with definite curative effect, high safety and high patient satisfaction, which is worthy of clinical application.